Hikma stock last trades at GBp 1,592.00 on September 28, 2026
Published on 09/28/2026 at 22:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hikma Pharmaceuticals PLC shares last traded at GBp 1,592.00 on the London Stock Exchange on September 28, 2026, at 15:35:03 UTC. The stock was up GBp 2.00, or 0.13 percent, from the previous session’s GBp 1,590.00.
Upcoming R&D investor seminars
In a September 22, 2026, release, Hikma said it will host three educational investor seminars focused on its research and development strategy and capabilities. The sessions are scheduled for October 20, November 24 and December 16, 2026, covering respiratory, nasal, semi-solids and liquids; solid orals; and injectables, respectively.
Hikma said it aspires to spend 5 percent to 6 percent of revenue on research and development going forward. The company also said the seminars will not provide new material financial or trading information and that its next scheduled trading update is due on November 5, 2026.
Epinephrine nasal spray under review
In a September 9, 2026, release, Hikma said regulators had accepted submissions for review for its investigational epinephrine nasal spray in the United States, Europe and the United Kingdom. Hikma also filed a submission in Canada.
The company described the product as a non-injectable treatment being developed for emergency use in allergic reactions, including anaphylaxis. Hikma said the product is investigational and has not been approved by the U.S. Food and Drug Administration.
